NCT05195203View on ClinicalTrials.gov

A Study of HS-10353 in Chinese Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

March 11, 2023

Study Completion Date

March 31, 2023

Conditions
Major Depressive Disorder
Interventions
DRUG

HS-10353

Single or multiple dose(s) of HS-10353

DRUG

Placebo

Single or multiple dose(s) of placebo

Trial Locations (1)

Unknown

West China Hospital, Chengdu

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY